Biotech

Warnex Moves Listing to the NEX

LAVAL, QUEBEC: ...

BASi Reports Further Improvement in Profitability Before Restructuring Charges for the Fourth Quarter of Fiscal 2012

WEST LAFAYETTE, IN: ...

Cellceutix Comments on New York Times Article Heralding p53 Drugs as the New Age in Cancer Research

BEVERLY, MA: ...

Sarepta Therapeutics Enters Into Clinical Trial Agreement With the National Institutes of Health for Further Development of Influenza Drug

CAMBRIDGE, MA: ...

Horizon Pharma to Receive Approval of DUEXIS(R) From the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA)

DEERFIELD, IL: ...

Stem Cell Therapeutics Announces Shareholder Approval of Share Consolidation Proposal

TORONTO, ONTARIO: ...

Clinical Update: Helix BioPharma Corp. Completes Enrollment in First Cohort and Initiates Second Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47

AURORA, ON: ...

Omni Bio Pharmaceutical Appoints New CEO

DENVER, CO: ...

The Medicines Company Announces Positive Trial Results for Oritavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

PARSIPPANY, NJ: SOLO-1 Trial Meets All Protocol-Specified Endpoints; One Single Intravenous Dose of Oritavancin Is Non-Inferior to Twice-Daily Vancomycin Intravenous Dosing for 7-10 Days ...

Crown Marketing Announces Smart Drug Delivery Revolution Has Arrived

CHAPEL HILL, NC: ...